Lessons learned from case fatality risk estimates of 2009 pandemic influenza

Epidemiology

Volumn 24, Issue 6, 2013, Pages 842-844

  Chowell, Gerardo ^a,b   Viboud, Cécile ^b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ANTIVIRAL THERAPY; FATALITY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; INFECTION RISK; MORTALITY; NOTE; PRIORITY JOURNAL; INFLUENZA; INFLUENZA VIRUS A H1N1; RISK;

HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; RISK;

EID: 84885365020     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/01.ede.0000434434.52506.bc     Document Type: Note

References (18)

1. Garske T, Legrand J, Donnelly CA, et al. Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ. 2009;339:b2840
2. Y u H, Cowling BJ, Feng L, et al. Human infection with avian influenza A H7N9 virus: An assessment of clinical severity. Lancet. 2013;382: 138-145
3. MER S-CoV summary and literature update -as of 09 July 2013. Available at: Http://www.who.int/csr/disease/coronavirus-infections/update-20130709/ en/index.html. Accessed 21 July 2013
4. Wong JY, Kelly H, Ip DKM, Wu JT, Leung GM, Cowling BJ. Case fatality risk of influenza A(H1N1pdm09): A systematic review. Epidemiology. 2013;24:830-841
5. Dawood FS, Iuliano AD, Reed C, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: A modelling study. Lancet Infect Dis. 2012;12:687-695
6. E chevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, et al. Infection and death from influenza A H1N1 virus in Mexico: A retrospective analysis. Lancet. 2009;374:2072-2079
7. Chowell G, Echevarría-Zuno S, Viboud C, et al. Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. PLoS Med. 2011;8:e1000436
8. Lipsitch M, Finelli L, Heffernan RT, Leung GM, Redd SC; 2009 H1n1 Surveillance Group. Improving the evidence base for decision making during a pandemic: The example of 2009 influenza a/H1n1. Biosecur Bioterror. 2011;9:89-115
9. Fraser C, Donnelly CA, Cauchemez S, et al.; WHO Rapid Pandemic Assessment Collaboration. Pandemic potential of a strain of influenza A (H1N1): Early findings. Science. 2009;324:1557-1561
10. Chowell G, Viboud C, Simonsen L, et al. Impact of antiviral treatment and hospital admission delay on the risk of death of 2009 A/H1N1 pandemic influenza in Mexico, April-December 2009. BMC Infect Dis. 2011;12:97
11. Torres JP, O'Ryan M, Herve B, et al. Impact of the novel influenza A (H1N1) during the 2009 autumn-winter season in a large hospital setting in Santiago, Chile. Clin Infect Dis. 2010;50:860-868
12. N ishiura H. The relationship between the cumulative numbers of cases and deaths reveals the confirmed case fatality ratio of a novel influenza A (H1N1) virus. Jpn J Infect Dis. 2010;63:154-156
13. Skowronski DM, De Serres G, Crowcroft NS, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: Four observational studies from Canada. PLoS Med. 2010;7:e1000258
14. Chowell G, Echevarria-Zuno S, Viboud C, et al. Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico. PLoS One. 2012;7:e41069
15. Chowell G, Bertozzi SM, Colchero MA, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med. 2009;361:674-679
16. Louie JK, Jean C, Acosta M, Samuel MC, Matyas BT, Schechter R. A review of adult mortality due to 2009 pandemic (H1N1) influenza A in California. PLoS One. 2011;6:e18221
17. Wilking H, Buda S, von der Lippe E, et al. Mortality of 2009 pandemic influenza A(H1N1) in Germany. Euro Surveill. 2010;15:19741
18. Presanis AM, De Angelis D, Hagy A, et al.; New York City Swine Flu Investigation Team. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: A Bayesian analysis. PLoS Med. 2009;6:e1000207